Within-host virus models with periodic antiviral therapy
From MaRDI portal
(Redirected from Publication:841791)
Abstract: This paper investigates the effect of drug treatment on the standard within-host HIV model, assuming that therapy occurs periodically. It is shown that eradication is possible under these periodic regimes, and we quantitatively characterize successful drugs or drug combinations, both theoretically and numerically. We also consider certain optimization problems, motivated for instance, by the fact that eradication should be achieved at acceptable toxicity levels to the patient. It turns out that these optimization problems can be simplified considerably, and this makes calculations of the optima a fairly straightforward task. All our results will be illustrated by means of numerical examples based on up-to-date knowledge of parameter values in the model.
Recommendations
- A within-host virus model with periodic multidrug therapy
- Periodic multidrug therapy in a within-host virus model
- Resonance of periodic combination antiviral therapy and intracellular delays in virus model
- Viral infection model with periodic lytic immune response
- scientific article; zbMATH DE number 1944177
- Within-host viral dynamics in a multi-compartmental environment
- Parsimonious models of in-host viral dynamics and immune response
- A viral model with intracellular delay and humoral immunity
- Dynamics of a viral infectiology under treatment
- Stability of virus infection models with antibodies and chronically infected cells
Cites work
- scientific article; zbMATH DE number 734901 (Why is no real title available?)
- scientific article; zbMATH DE number 2038872 (Why is no real title available?)
- Drug-sparing regimens for HIV combination therapy: Benefits predicted for ``drug coasting
- Emergence of HIV-1 drug resistance during antiretroviral treatment
- Mathematical Analysis of HIV-1 Dynamics in Vivo
- Modeling within-host evolution of HIV: mutation, competition and strain replacement
- Multistrain virus dynamics with mutations: a global analysis
- Optimal control of the chemotherapy of HIV
- Periodically varying antiviral therapies: conditions for global stability of the virus free state
- Predicting differential responses to structured treatment interruptions during HAART
- Production of resistant HIV mutants during antiretroviral therapy
- Virus Dynamics: A Global Analysis
Cited in
(17)- Stochastic dynamics of HIV models with switching parameters and pulse control
- Mathematical analysis of an HIV model with impulsive antiretroviral drug doses
- Within-host demographic fluctuations and correlations in early retroviral infection
- Permanence and extinction of a non-autonomous HIV-1 model with time delays
- Minimizing R₀ for in-host virus model with periodic combination antiviral therapy
- Within-host viral dynamics in a multi-compartmental environment
- Periodically varying antiviral therapies: conditions for global stability of the virus free state
- A mathematical model for HIV treatment with time-varying antiretroviral therapy
- Resonance of periodic combination antiviral therapy and intracellular delays in virus model
- A viral infection model with immune circadian rhythms
- A diffusive virus model with a fixed intracellular delay and combined drug treatments
- Periodic multidrug therapy in a within-host virus model
- Mathematical analysis of an HIV infection model including quiescent cells and periodic antiviral therapy
- A mathematical study of the implicit role of innate and adaptive immune responses on within-human \textit{Plasmodium falciparum} parasite levels
- A within-host virus model with periodic multidrug therapy
- A within-host virus model with multiple infected stages under time-varying environments
- Existence of positive periodic solutions of several types of biological models with periodic coefficients
This page was built for publication: Within-host virus models with periodic antiviral therapy
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q841791)
